REGENXBIO Inc. (RGNX) Q2 2025 Earnings Call

Investor webinar replay

Replay transcript excerpt

Welcome everyone to the second quarter 2025 RegeneX Bio earnings conference call. If you would like to ask a question during this time, simply press star followed by the number one on your telephone keypad. If you would like to withdraw your question, again press the star one. Please note, slide reference during this call are available in the webcast and at the events page of RegeneX Bio's website. At this time, I'd like to turn the conference over to Patrick Christmas, Chief Legal Officer of RegeneX Bio. Please go ahead. Good morning and thank you for joining us today. Earlier this morning, RegeneX Bio released financial and operating results for the second quarter and the June 30th, 2025. The press release is available on our website at .regenxbio.com. Today's conference call will include forward-looking statements regarding our financial outlook in addition to regulatory and product development plans. These forward-looking statements are subject to risks and uncertainties that may cause actual results to differ from those forecasted and can be identified by words such as expect, plan, will, may, anticipate, believe, should, intend, and other words of similar meaning. Any such forward-looking statements are not guarantees of future performance and involve certain risks and uncertainties. These risks are described in the risk factors in the management's discussion and analysis section of RegeneX Bio's annual report on Form 10-K for the full year ended December 31, 2024, and comparable risk factor sections of RegeneX Bio's quarterly reports on Form 10-Q, which are on file with the Securities and Exchange Commission and available on the SEC's website. Any information we provide on this conference call is provided only as of the date of this call, August 7, 2025, and w...